Point72 Hong Kong Ltd - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$146,000
+284.2%
4,753
+298.1%
0.01%
+400.0%
Q1 2022$38,000
-35.6%
1,194
-9.5%
0.00%
-50.0%
Q4 2021$59,000
+31.1%
1,319
+46.7%
0.00%
+100.0%
Q3 2021$45,000
+2150.0%
899
+649.2%
0.00%0.0%
Q1 2020$2,000
-99.0%
120
-99.1%
0.00%
-99.4%
Q4 2017$204,00013,0430.16%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders